Reports and Whitepapers
- An Economic Growth and Competitiveness Agenda For California - Aug 3, 2011
For over a decade, California has lacked a comprehensive economic and workforce development strategy, leading to a severe lack of focus and inefficiency in California’s ability to work... - California Biomedical Industry Report 2011 Report - Feb 11, 2011
For the first time ever, BayBio and CHI have collaborated with PwC to produce one unified report o the biomedical industry in California. The 2011 California Biomedical Industry Report... - California Biomedical Industry Report 2012 Report - Feb 8, 2012
Produced in collaboration with CHI, PwC and BayBio, the report analyzes the state of the industry in California. - Competitiveness and Regulation: The FDA and the Future of America's Biomedical Industry - Feb 17, 2011
CHI and BCG's report highlights the critical role of the U.S. Food and Drug Administration (FDA) in today’s biomedical research and innovation ecosystem. - FDA Impact on U.S. Medical Technology Innovation - Feb 11, 2011
Dr. Josh Makower led a study that details how patients in Europe are getting access to new therapies an average of two years before patients in the United States due to regulatory... - Gone Tomorrow? A Call to Promote Medical Innovation, Create Jobs and Find Cures in America - Feb 11, 2011
The Council for American Medical Innovation (CAMI), launched in 2009, has brought together leaders in research, medicine, public health, academia, education, labor, and business, who... - Outsourcing in Life Sciences: A Survey of BayBio Members - Apr 9, 2012
This report represents an empirical assessment of clinical development outsourcing among BayBio members and life science and pharmaceutical firms outside the San Francisco Bay Area. - The Biopharmaceutical Sector’s Impact on the Economy of California - May 11, 2011
This fact sheet presents ananalysis of the impact of the biopharmaceutical sector on the economy of California (CA) in 2008, including data on employment, economic output, and research and... - The JOBS Act and General Solicitation: Impact on Private Offerings During the Period Prior to SEC - Apr 6, 2012
President Obama today signed into law the Jumpstart Our Business Startups Act (JOBS Act). Title II of the JOBS Act affects offerings by issuers pursuant to Regulation D under the Securities Act,... - Unleashing the Promise of Biotechnology - Aug 8, 2011
Advancing American Innovation to Cure Disease and Save Lives
